$174.3 Million
Ventyx Biosciences
Initial Public Offering
Active Bookrunner
$190.6 Million
Nuvalent
Initial Public Offering
Active Bookrunner
$255.0 Million
Monte Rosa Therapeutics
Initial Public Offering
Active Bookrunner
$515.7 Million
Privia Health Group, Inc.
Initial Public Offering
Active Bookrunner
$75.0 Million
Minerva Surgical Inc.
Initial Public Offering
Active Bookrunner
$184.0 Million
Day One Biopharmaceuticals, Inc.
Initial Public Offering
Active Bookrunner
$144.9 Million
CVRx, Inc.
Initial Public Offering
Active Bookrunner
$242.0 Million
Century Therapeutics, Inc.
Initial Public Offering
Active Bookrunner
$176.0 Million
Biomea Fusion
Initial Public Offering
Active Bookrunner
$284.7 Million
Cytek Biosciences, Inc.
Initial Public Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.